Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of the Delta variant on vaccine efficacy and response strategies
Lianlian Bian, Qiushuang Gao, Fan Gao, et al.
Expert Review of Vaccines (2021) Vol. 20, Iss. 10, pp. 1201-1209
Open Access | Times Cited: 215

Showing 26-50 of 215 citing articles:

Revisiting COVID-19 policies: 10 evidence-based recommendations for where to go from here
Daniel T. Halperin, Norman Hearst, Stephen Hodgins, et al.
BMC Public Health (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 39
SARS-CoV-2 subunit vaccine adjuvants and their signaling pathways
Daniel Mekonnen, Hylemariam Mihiretie Mengist, Tengchuan Jin
Expert Review of Vaccines (2021) Vol. 21, Iss. 1, pp. 69-81
Open Access | Times Cited: 38
A Bivalent COVID-19 Vaccine Based on Alpha and Beta Variants Elicits Potent and Broad Immune Responses in Mice against SARS-CoV-2 Variants
Rui Wang, Chunyun Sun, Juan Ma, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 702-702
Open Access | Times Cited: 24
Variants of SARS CoV-2: mutations, transmissibility, virulence, drug resistance, and antibody/vaccine sensitivity
Birgit M. Prü
Frontiers in Bioscience-Landmark (2022) Vol. 27, Iss. 2, pp. 065-065
Open Access | Times Cited: 22
Molecular aspects of Omicron, vaccine development, and recombinant strain XE: A review
K. Akash, Avinash Sharma, Deepak Kumar, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 10, pp. 4628-4643
Open Access | Times Cited: 22
Real-World Effectiveness of Mix-and-Match Vaccine Regimens against SARS-CoV-2 Delta Variant in Thailand: A Nationwide Test-Negative Matched Case-Control Study
Rapeepong Suphanchaimat, Natthaprang Nittayasoot, Chuleeporn Jiraphongsa, et al.
Vaccines (2022) Vol. 10, Iss. 7, pp. 1080-1080
Open Access | Times Cited: 22
Variants of SARS-CoV-2: Influences on the Vaccines’ Effectiveness and Possible Strategies to Overcome Their Consequences
Ali A. Rabaan, Shamsah H. Al-Ahmed, Hawra Albayat, et al.
Medicina (2023) Vol. 59, Iss. 3, pp. 507-507
Open Access | Times Cited: 13
Risk of hospitalization and vaccine effectiveness among COVID-19 patients in the UAE during the Delta and Omicron outbreaks
Mohammed Albreiki, Mira Mousa, Syafiq Kamarul Azman, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
SARS‐CoV‐2 omicron variant: Could it be another threat?
Balamurugan Shanmugaraj, Ashwini Malla, Narach Khorattanakulchai, et al.
Journal of Medical Virology (2021) Vol. 94, Iss. 4, pp. 1284-1288
Open Access | Times Cited: 31
The fine-scale associations between socioeconomic status, density, functionality, and spread of COVID-19 within a high-density city
Anshu Zhang, Wenzhong Shi, Chengzhuo Tong, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 20
mRNA COVID‐19 vaccine and oral lichen planus: A case report
Mario Caggiano, Massimo Amato, Federica Di Spirito, et al.
Oral Diseases (2022) Vol. 28, Iss. S2, pp. 2624-2626
Open Access | Times Cited: 19
Genomic diversity of SARS‐CoV‐2 in Pakistan during the fourth wave of pandemic
Massab Umair, Aamer Ikram, Zaira Rehman, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 10, pp. 4869-4877
Open Access | Times Cited: 19
Sputnik V protection from COVID-19 in people living with HIV under antiretroviral therapy
Vladimir А. Gushchin, Е. В. Цыганова, Darya A. Ogarkova, et al.
EClinicalMedicine (2022) Vol. 46, pp. 101360-101360
Open Access | Times Cited: 18
Omicron-included mutation-induced changes in epitopes of SARS-CoV-2 spike protein and effectiveness assessments of current antibodies
Guo Du, Huaichuan Duan, Yan Cheng, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 18
Risk Factors for Coronavirus Disease 2019 (COVID-19)-Associated Pulmonary Aspergillosis in Critically Ill Patients: A Nationwide, Multicenter, Retrospective Cohort Study
Si‐Ho Kim, Jin Yeong Hong, Seongman Bae, et al.
Journal of Korean Medical Science (2022) Vol. 37, Iss. 18
Open Access | Times Cited: 18
Clinical characteristics and immune profile alterations in vaccinated individuals with breakthrough Delta SARS-CoV-2 infections
Qinghong Fan, Jingrong Shi, Yanhong Yang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 18
Towards precision medicine: Omics approach for COVID-19
Xiaoping Cen, Feng-ao Wang, Xinhe Huang, et al.
Biosafety and Health (2023) Vol. 5, Iss. 2, pp. 78-88
Open Access | Times Cited: 11
Computational analysis of the sequence-structure relation in SARS-CoV-2 spike protein using protein contact networks
Pietro Hiram Guzzi, Luisa Di Paola, Barbara Puccio, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Deep learning for COVID-19 topic modelling via Twitter: Alpha, Delta and Omicron
Janhavi Lande, Arti Pillay, Rohitash Chandra
PLoS ONE (2023) Vol. 18, Iss. 8, pp. e0288681-e0288681
Open Access | Times Cited: 10
Nanobody repertoire generated against the spike protein of ancestral SARS-CoV-2 remains efficacious against the rapidly evolving virus
Natalia E. Ketaren, Fred D. Mast, Peter C. Fridy, et al.
eLife (2024) Vol. 12
Open Access | Times Cited: 3
SARS-CoV-2 Evolution: Implications for Diagnosis, Treatment, Vaccine Effectiveness and Development
Fabrizio Angius, Silvia Puxeddu, S Zaimi, et al.
Vaccines (2024) Vol. 13, Iss. 1, pp. 17-17
Open Access | Times Cited: 3
COVID-19 Booster Vaccines Administration in Different Countries
Angel Yun-Kuan Thye, Loh Teng‐Hern Tan, Jodi Woan‐Fei Law, et al.
Progress In Microbes & Molecular Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 26
Interspecies Jumping of Bat Coronaviruses
Antonio C. P. Wong, Susanna K. P. Lau, Patrick C. Y. Woo
Viruses (2021) Vol. 13, Iss. 11, pp. 2188-2188
Open Access | Times Cited: 24
The Impact of COVID-19 on Mortality in Italy: Retrospective Analysis of Epidemiological Trends
Alessandro Rovetta, Akshaya Srikanth Bhagavathula
JMIR Public Health and Surveillance (2022) Vol. 8, Iss. 4, pp. e36022-e36022
Open Access | Times Cited: 17
Retrospective Cohort Study of the Effectiveness of the Sputnik V and EpiVacCorona Vaccines against the SARS-CoV-2 Delta Variant in Moscow (June–July 2021)
O. V. Matveeva, А. В. Ершов
Vaccines (2022) Vol. 10, Iss. 7, pp. 984-984
Open Access | Times Cited: 16

Scroll to top